Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Lyka Labs
|
Zim Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-23.88 % | 145.3 % | 6.88 % |
|
5yr average Equity Multiplier
|
1.78 | -0.06 | 1.92 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.64 | 0.96 |
|
5yr Avg Net Profit Margin
|
-23.79 % | -21.64 % | 3.75 % |
|
Price to Book
|
7.33 | 4.19 | 1.83 |
|
P/E
|
0.0 | 100.65 | 28.92 |
|
5yr Avg Cash Conversion Cycle
|
-10.34 Days | 16.94 Days | 35.7 Days |
|
Inventory Days
|
93.5 Days | 26.54 Days | 67.21 Days |
|
Days Receivable
|
66.75 Days | 77.33 Days | 97.06 Days |
|
Days Payable
|
179.8 Days | 133.6 Days | 149.76 Days |
|
5yr Average Interest Coverage Ratio
|
-11.84 | 0.6 | 3.65 |
|
5yr Avg ROCE
|
-15.03 % | 22.35 % | 13.04 % |
|
5yr Avg Operating Profit Margin
|
-13.23 % | 20.24 % | 11.53 % |
|
5 yr average Debt to Equity
|
0.21 | -0.79 | 0.42 |
|
5yr CAGR Net Profit
|
0.22 % | -47.18 % | 39.21 % |
|
5yr Average Return on Assets
|
-14.62 % | -5.63 % | 3.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 58.16 % | 33.26 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | 10.37 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | -0.72 % | 0.0 |
|
Brooks Laboratories
|
Lyka Labs
|
Zim Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|